[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 14, 2004

Memantine for Patients With Alzheimer Disease

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(14):1695. doi:10.1001/jama.291.14.1695-a

To the Editor: Dr Tariot and colleagues1 reported that among patients with moderate to severe Alzheimer disease (AD) receiving stable doses of donepezil, memantine resulted in significantly better outcomes than placebo on measures of cognition, activities of daily living, global outcome, and behavior and was well-tolerated. However, the authors did not describe whether the caregivers of these patients noticed a difference or whether life was made better for them or for the patients.

First Page Preview View Large
First page PDF preview
First page PDF preview
×